about
Differentiation between severe HELLP syndrome and thrombotic microangiopathy, thrombotic thrombocytopenic purpura and other imitators.Mechanistic analysis of nonoxygenated hypothermic machine perfusion's protection on warm ischemic kidney uncovers greater eNOS phosphorylation and vasodilation.Functional outcome of prolonged refractory status epilepticus.Influence of ICU-bed availability on ICU admission decisions.Strategies to optimize kidney recovery and preservation in transplantation: specific aspects in pediatric transplantation.Should we carry out noninvasive ventilation using a helmet in acute respiratory distress syndrome?ADAMTS13 deficiency in severe postpartum HELLP syndrome.Preoxygenation with non-invasive ventilation versus high-flow nasal cannula oxygen therapy for intubation of patients with acute hypoxaemic respiratory failure in ICU: the prospective randomised controlled FLORALI-2 study protocol.Early Identification of Acute Respiratory Distress Disorder in the Absence of Positive Pressure Ventilation: Implications for Revision of the Berlin Criteria for Acute Respiratory Distress Syndrome.Predictors of Intubation in Patients With Acute Hypoxemic Respiratory Failure Treated With a Noninvasive Oxygenation Strategy.Beneficial Effects of Noninvasive Ventilation in Acute Hypoxemic Respiratory Failure: Caution With Findings From Meta-Analyses.Could Noninvasive Ventilation Failure Rates Be Underestimated in the LUNG SAFE Study?Modulation by Polymyxin-B Hemoperfusion of Inflammatory Response Related to Severe Peritonitis.Acute Hypercapnic Respiratory Failure Due to Exacerbation of Chronic Obstructive Pulmonary Disease: Who Are the Patients Most at Risk for Intubation?Use of Type III procollagen measurement as predictor of lung fibroproliferation in ARDS: early measurement for earlier antifibroproliferative therapy?Impact of sleep alterations on weaning duration in mechanically ventilated patients: a prospective study.Multicentric standardized flow cytometry routine assessment of septic patient to predict clinical worsening.Effect of non-invasive remote ischemic preconditioning on intra-renal perfusion in volunteers.Images in gerontology: a case report.Is skin mottling a predictor of high mortality in non-selected patients with cirrhosis admitted to intensive care unit?High-flow nasal cannula oxygen therapy alone or with non-invasive ventilation during the weaning period after extubation in ICU: the prospective randomised controlled HIGH-WEAN protocolNon-invasive ventilation or high-flow oxygen therapy: When to choose one over the other?Clinical features and outcome of patients with acute respiratory failure revealing anti-synthetase or anti-MDA-5 dermato-pulmonary syndrome: a French multicenter retrospective studyHigh-flow nasal cannula oxygen therapy in immunocompromised patients: where? for whom? and when to stop?Accuracy of fluoropropyl-2beta-carbomethoxy-3beta-(4- iodophenyl) nortropane datscan for the diagnosis of lewy body dementiaRepetitive gas embolisms after central catheter removal[Fatal fulminant varicella-zoster virus hepatitis in a female patient with Crohn's disease treated by an anti-TNF-alpha agent]Tidal volume and non-invasive ventilation failure - Authors' replyNoninvasive Ventilation and Outcomes Among Immunocompromised PatientsPredictors of successful separation from high-flow nasal oxygen therapy in patients with acute respiratory failure: a retrospective monocenter studyMechanism of airway closure in acute respiratory distress syndrome: a possible role of surfactant depletionInfluence of Hypoxic Preservation Temperature on Endothelial Cells and Kidney IntegrityAcute Respiratory Distress Syndrome: Respiratory Monitoring and Pulmonary PhysiologyHigh-Flow Oxygen Therapy for Respiratory Failure in Immunocompromised PatientsNon-invasive ventilation versus high-flow nasal cannula oxygen therapy with apnoeic oxygenation for preoxygenation before intubation of patients with acute hypoxaemic respiratory failure: a randomised, multicentre, open-label trialHigh-flow nasal oxygen therapy alone or with non-invasive ventilation in immunocompromised patients admitted to ICU for acute hypoxemic respiratory failure: the randomised multicentre controlled FLORALI-IM protocolIs immunosuppression status a risk factor for noninvasive ventilation failure in patients with acute hypoxemic respiratory failure? A post hoc matched analysisCAPS criteria fail to identify most severely-ill thrombotic antiphospholipid syndrome patients requiring intensive care unit admissionImpact of sleep alterations on weaning duration of mechanically ventilated patients: how much is bad?The authors reply
P50
Q33422067-02184525-D23F-4916-BE7E-A2E74BD2DEFCQ35324163-6E289DF3-5E2C-46C8-B91E-2E2BA2C6107FQ35590568-9D0D2919-3621-4EB3-894A-8FCA28E4740AQ36415370-C113AA1B-207E-459D-8862-33F8E0CEBC67Q38245855-3479ECD3-BD31-44EC-AF1A-BCBCBE2346F6Q42382706-45A7E2BB-2842-4AD9-B057-C91705FDF8F4Q45130089-5EF2D70D-C3C9-4683-8368-C82F3BB4D188Q47217974-2DB36B39-2112-4C16-BB2E-9CB31487ECFDQ47672035-B4680ACA-DBC8-4401-9007-DB43014FEC9DQ47724501-5CE517AC-697B-41D9-B51F-1F52232C6AE7Q47771884-456A4CA3-182E-45FF-830A-43B0705A0410Q47966830-211B6D26-692A-40E9-B393-D39F392D01E4Q51006750-6782BBFD-AA37-41FE-967B-BFBC38F66A8CQ51621273-CC708BD5-F11D-4351-BBF6-D4F50C46CDF1Q51641148-6E16FFF2-EB7D-4D01-946C-0E55480B3840Q52665780-8B10B2EB-68A5-4D71-8633-3CC48C1FE7ADQ52715989-9E2CD044-4948-4A07-954E-C25AE91D4636Q53096255-C3AB0499-B420-486D-AC7C-7D69C1E79275Q53336715-41F4F89F-B828-46FE-9860-259CBFD151A6Q53474707-1A3A5DC3-22AD-428A-B505-F2D3BF9D71EEQ56515705-75FAC8DF-1F06-4B7F-BD3D-9EBD3645550DQ58589286-8A16BFD8-FFE1-4612-A022-15C600663E33Q58752627-ACBC351F-00A8-44C8-AEF4-C3D3B7E51068Q64885959-6D9F0AE0-FE03-495D-9064-4E727FE1B11AQ82734206-DBB48BC9-2848-49B4-82C1-706A9080DE65Q83405191-00FD8497-005A-49AA-B9B3-21C28103C6A8Q85647619-069E0B10-F8A9-4A19-8D35-876350A94FFFQ88661471-5B0B4B3C-1F13-4146-92BC-F44D69F12DE3Q89356606-3A407090-3610-4E2B-8DFC-DC6AF7A45EF5Q90070550-C61B725E-4939-4514-9484-88C15D698F2AQ90601230-11DEB8AA-2ECB-488E-A1E2-DB2D14F08C44Q91645355-A82D9201-DDBC-4CD0-B941-0E05A41D0C87Q91794544-DE55428E-3017-42BE-B1CE-5BE4A7D83116Q92005333-2DEADB90-F0DF-41E9-B9A5-AD0D47510C62Q92535180-5B50B9E5-9E3C-45CD-BC6F-21703731DA27Q92547446-D9F2E88F-4BB6-43BA-A5FA-604DBF6A612AQ92630577-BEE9D3DA-CFE6-4F0C-BEE2-B40F0112047BQ93113883-1F0460E1-063C-495D-A6DC-A8169FE896B6Q95592232-6B59D0A3-EEF6-4109-A510-AF7939C72AF0Q95597424-863B3636-99F9-4C41-916D-5B8FC0293014
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Rémi Coudroy
@en
Rémi Coudroy
@nl
type
label
Rémi Coudroy
@en
Rémi Coudroy
@nl
prefLabel
Rémi Coudroy
@en
Rémi Coudroy
@nl
P31
P496
0000-0002-0036-1899